David Smadja: Unveiling the Endothelium’s Role in Thrombosis at ISTH 2026
David Smadja, Professor of Hematology (PU-PH) at Paris Cité University, European Georges Pompidou Hospital, shared RFHT – Revue Francophone d’Hémostase et Thrombose‘s post on LinkedIn, adding:
“A look back at ISTH 2026 in Paris.
A few minutes to talk about a subject that has fascinated me for many years: the role of the endothelium in thrombosis.
Long considered a simple interface between the blood and the tissues, the endothelium is in fact a major player in vascular balance and its dysregulation.
Inflammation, coagulation activation, thrombosis: a better understanding of the dialogue between endothelium, blood and vessels opens up new perspectives for understanding, preventing and perhaps better treating thrombotic diseases in the future.
Thank you to the RFHT – French-Language Journal of Hemostasis and Thrombosis for this series of short videos that extend ISTH’s scientific exchanges beyond the congress.”
RFHT – Revue Francophone d’Hémostase et Thrombose shared a post on LinkedIn, adding:
“The essentials of ISTH 2026 deciphered in interviews – Part 2
- How can you go even further with emicizumab? Cedric Hermans, Liège, Belgium
- NETs in all their facets: formation, fate and elimination, Chloé James, Bordeaux
- API-CAT: what do we know about venous thromboembolic recurrences with apixaban? Isabelle Mahé, Colombes
- What clinical lessons can be learned from the 3-year data from the CASSIOPEIA study on venous thromboembolism? Laurent Frenzel, New York, United States
- Von Willebrand disease: should the 2B variants be reclassified New York? Melanie Daniel, Lille
- Endothelial cells: a new role in the mechanisms of thrombosis? David Smadja, Paris
- Post-MTEV patient-caregiver communication session: a new tool to improve living better with one’s pathology? Francis Couturaud, Brest
- Can we still improve the prevention of thrombotic risk? Catherine Lemarie, Brest.”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 10:48Tareq Abadl: When and Why Do We Perform Weak D Testing?
-
Sep 6, 2026, 10:19Faezeh Kheyri: Exploring the Future of Immunohematology with Artificial Intelligence
-
Sep 6, 2026, 05:58Mohamed F Doheim: ‘Stroke as a Symphony’ – Rethinking Decision-Making in Acute Ischemic Stroke
-
Sep 6, 2026, 05:26Yousef Hindi: Unprovoked Left Renal Vein Thrombosis and Severe IDA – Long-Term Resolution and Dual-Energy CT Findings
-
Sep 6, 2026, 05:18Robert Brown: Standardizing Amniotic Fluid Embolism Diagnosis – SMFM and AFE Foundation Criteria
-
Sep 6, 2026, 04:45Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
-
Sep 6, 2026, 04:38M. Ibrahim Siddique: Does Routine Triple Therapy Pay Off After Anterior STEMI?
-
Sep 6, 2026, 04:29Sandra Revill Tremulis: The Lp(a)HORIZON Topline Results Raise Important Questions Beyond Simply ‘Does Lowering Lp(a) Work?’
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE